High Intensity Focused Ultrasound‐Driven Nanomotor for Effective Ferroptosis‐Immunotherapy of TNBC
Advanced Science · 2024
DOI: 10.1002/advs.202305546 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Xiangrong Yu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment Zhuhai People's Hospital (Zhuhai Hospital Affiliated with Jinan U…. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Ferroptosis. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Project of Zhuhai City Department of Science and Technology.
Abstract (Originalsprache)
The heterogeneity of triple‐negative breast cancers (TNBC) remains challenging for various treatments. Ferroptosis, a recently identified form of cell death resulting from the unrestrained peroxidation of phospholipids, represents a potential vulnerability in TNBC. In this study, a high intensity focused ultrasound (HIFU)‐driven nanomotor is developed for effective therapy of TNBC through induction of ferroptosis. Through bioinformatics analysis of typical ferroptosis‐associated genes in the FUSCCTNBC dataset, gambogic acid is identified as a promising ferroptosis drug and loaded it into the nanomotor. It is found that the rapid motion of nanomotors propelled by HIFU significantly enhanced tumor accumulation and penetration. More importantly, HIFU not only actuated nanomotors to trigger effective ferroptosis of TNBC cells, but also drove nanomotors to activate ferroptosis‐mediated antitumor immunity in primary and metastatic TNBC models, resulting in effective tumor regression and prevention of metastases. Overall, HIFU‐driven nanomotors show great potential for ferroptosis‐immunotherapy of TNBC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment Zhuhai People's Hospital (Zhuhai Hospital Affiliated with Jinan University), Zhuhai, Guangdong, 519000, P. R. China.
- Key Laboratory of Smart Drug Delivery, School of Pharmacy, Fudan University, Shanghai, 201203, P.R. China.
- State Key Laboratory of Genetic Engineering, School of Life Sciences and Human Phenome Institute, Fudan University, 2005 Songhu Road, Shanghai, 200438, P.R. China.
- Department of Radiology, Huashan Hospital, State Key Laboratory of Medical Neurobiology, Fudan University, 12 Wulumuqi Middle Road, Shanghai, 200040, China.
- State Key Laboratory of Molecular Engineering of Polymers & Department of Macromolecular Science, Fudan University, Shanghai, 200433, China.
ORCID-Profile: Zhiqing Pang
Förderung
- National Natural Science Foundation of China
- Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment
- Project of Zhuhai City Department of Science and Technology
- Program of the Shanghai Academic Research Leader
- The state key program of the National Natural Science Foundation of China
Zitieren
APA
Yu, X., Li, X., Chen, Q., Wang, S., Xu, R., He, Y., Qin, X., Zhang, J., Yang, W., Shi, L., Lu, L., Zheng, Y., Pang, Z., & Peng, S. (2024). High Intensity Focused Ultrasound‐Driven Nanomotor for Effective Ferroptosis‐Immunotherapy of TNBC. Advanced Science. https://doi.org/10.1002/advs.202305546
Vancouver
Yu X, Li X, Chen Q, Wang S, Xu R, He Y, et al. High Intensity Focused Ultrasound‐Driven Nanomotor for Effective Ferroptosis‐Immunotherapy of TNBC. Advanced Science. 2024. doi:10.1002/advs.202305546
BibTeX
@article{Yu2024,
author = {Yu, Xiangrong and Li, Xuejing and Chen, Qingwang and Wang, Siyu and Xu, Ruizhe and He, Ying and Qin, Xifeng and Zhang, Jun and Yang, Wuli and Shi, Leming and Lu, Ligong and Zheng, Yuanting and Pang, Zhiqing and Peng, Shaojun},
title = {High Intensity Focused Ultrasound‐Driven Nanomotor for Effective Ferroptosis‐Immunotherapy of TNBC},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202305546}
}
EUVIMED